If side effects appear after you return home from hair loss treatment in Japan, the first step depends on how you feel. Sudden trouble breathing, chest pain, facial swelling, or thoughts of harming yourself require local emergency care.
You can start with a local doctor or pharmacist if a side effect is mild, followed by a note to your Japanese clinic.
A local clinician can examine you and treat the immediate problem. A pharmacist can check whether another medicine is adding to the reaction. After that, tell the clinic in Japan that prescribed the medicine.
First, decide how urgent it is
Begin by focusing on your symptoms rather than the distance to a healthcare facility. If you are experiencing severe or rapidly worsening symptoms, seek local care immediately.
For mild or moderate symptoms, you can wait to schedule a local appointment or consult with a pharmacist. However, it’s still beneficial to write down the date and details of what you’ve observed.
Who to contact first
| Symptom | First contact | Tell your Japanese clinic |
|---|---|---|
| Sudden trouble breathing, chest pain, or facial swelling | Local emergency department | After you have contacted the local emergency department |
| Thoughts of self-harm or a major drop in mood | Local emergency department | After immediate care, with the medicine name |
| Sexual side effects, breast tenderness, or mild mood change | Local doctor or pharmacist | Yes, with doses and start dates |
| Scalp redness, itching, flaking, or extra shedding | Local doctor or pharmacist | Yes, if it continues or worries you |
After you contact them, write a short note on your phone. Record the date, time, symptom, and what the local clinician said.
Side effects reported with treatment
Side effects vary by medication and individual. The main pattern depends on whether an oral 5-alpha reductase inhibitor like finasteride or dutasteride was taken, topical minoxidil was used, or treatments were combined.
Oral finasteride or dutasteride
Reported sexual side effects include reduced libido, erectile dysfunction, and ejaculation problems. Japanese medication instructions also list breast tenderness, depressed mood, and liver dysfunction.
In a systematic review, sexual side effects were reported by 1.9% to 6.7% of men assigned to treatment and 0.9% to 3.9% assigned to placebo, and most were mild and improved after stopping.1
A meta-analysis of 15 randomized, placebo-controlled trials found that treatment with finasteride or dutasteride was associated with a 1.57 times higher risk of sexual dysfunction.2
It does not mean every man will have this problem, but doctors should ask about sexual function during follow-up.
Post-marketing reports and Japanese labeling note that some sexual symptoms have continued after the medicine was stopped. Information on these side effects is limited, because safety reporting in finasteride trials has often been incomplete.
Among 34 trials, 26 had a safety evaluation period of one year or less.3 Mood findings are mixed. One systematic review found depressive symptoms in 3.33% of people who took finasteride and 2.54% of people who did not, with an odds ratio of 2.14.4
A large cohort analysis found no significant link between finasteride and depression or suicide after correction.5 Japanese labeling for finasteride states to stop the medicine and contact a doctor right away if suicidal thoughts or attempts appear.
Topical minoxidil
Topical minoxidil usually affects the scalp where it is applied. The most common side effect is contact dermatitis, which can look like redness, itching, or flaking. Some men also notice a short period of increased shedding when they first start the medicine.
The rash can come from an allergy or irritation, and a doctor can tell the difference with a patch test. A local doctor or pharmacist can help you decide whether to continue.
What to tell a local doctor or pharmacist
Give the doctor or pharmacist a clear list of what you used and when. Name the active ingredient rather than relying only on a brand, because brand names differ by country.
- The active ingredient and dose
- The date you started the medicine
- The date and timing of each new symptom
- All other medicines and supplements you take
- The clinic in Japan that prescribed the medicine
Keep a short written log every day. This helps a local clinician separate a drug reaction from an unrelated illness, and you can send the same note to the clinic in Japan.
Updating your Japanese clinic from home
For non-urgent side-effect reports, please use the clinic’s contact form. Keep in mind that replies will be sent by email, so this form is not suitable for emergencies.
In the message, include your name, the medicine, the dose, the start date, the symptom and its first date, and what your local doctor said. The clinic accepts side-effect-related contact by email or phone, but phone support is in Japanese only.
Do not wait for a reply before treating a symptom that feels severe. Start local care first, then send the update.
When side effects should change your treatment
A new side effect does not always mean you must stop, but it does mean the prescribing doctor should review the risk and benefit. Do not change the dose on your own, because stopping some hair loss medicines can restart the underlying hair loss.
If the symptom is mild, a doctor may suggest watching it, changing how you apply a topical product, or checking other causes. If the symptom is serious or affects your mood or sexual function, make the decision with a clinician and let your Japanese clinic know.
If you need follow-up after returning home, send the details to our clinics in Tokyo and Yokohama, Japan. Our doctors will listen to your concerns and questions about the side effects you notice.
Frequently asked questions
- Should I stop my hair loss medicine if I notice sexual side effects?
-
Do not stop on your own unless a symptom is severe or a clinician tells you to stop. Many sexual side effects in the clinical trials were mild and improved after the medicine was stopped.
The next step usually begins with a local doctor or a message to your Japanese clinic, who can help you decide whether to pause.
- What should I do if I feel very low or have thoughts of self-harm after returning home?
-
Seek local help the same day. Go to the nearest emergency department or have someone take you there, and tell the clinician exactly which medicine you take and when you started it.
Japanese labeling for finasteride says to stop the medicine and contact a doctor right away if suicidal thoughts appear. After you are safe, ask the treating clinician to share the report with the clinic in Japan.
- Can my Japanese clinic prescribe or send medicine after I report side effects from abroad?
-
The clinic can receive your report and discuss next steps, but it cannot ship medicine to your home country. Replies to the English form come by email, which suits follow-up rather than urgent symptoms.
Phone support is available, but the call is handled in Japanese only. If a local doctor needs information from Japan, include that request in the form.
- What details should I include in the form?
-
Include the active ingredient and dose, the start date, the symptom and the date it began, other medicines and supplements, and anything your local doctor said. One short, dated list is easier for the clinic to read than several separate messages.
References
1. Złotowska, A., Jastrząb-Miśkiewicz, B., & Krajewski, P. K. (2026). Sexual dysfunction associated with 5α-reductase inhibitors in the treatment of androgenetic alopecia: a systematic review. Frontiers in Medicine, 13, 1787706. https://doi.org/10.3389/fmed.2026.1787706
2. Lee, S., Lee, Y. B., Choe, S. J., & Lee, W. S. (2019). Adverse Sexual Effects of Treatment with Finasteride or Dutasteride for Male Androgenetic Alopecia: A Systematic Review and Meta-analysis. Acta Dermato-venereologica, 99(1), 12-17. https://doi.org/10.2340/00015555-3035
3. Belknap, S. M., Aslam, I., Kiguradze, T., Temps, W. H., Yarnold, P. R., Cashy, J., Brannigan, R. E., Micali, G., Nardone, B., & West, D. P. (2015). Adverse Event Reporting in Clinical Trials of Finasteride for Androgenic Alopecia: A Meta-analysis. JAMA Dermatology, 151(6), 600-6. https://doi.org/10.1001/jamadermatol.2015.36
4. Pompili, M., Magistri, C., Maddalena, S., Mellini, C., Persechino, S., & Baldessarini, R. J. (2021). Risk of Depression Associated With Finasteride Treatment. Journal of Clinical Psychopharmacology, 41(3), 304-309. https://doi.org/10.1097/JCP.0000000000001379
5. Wang, J., Lin, D., Zhao, J., Wei, S., Wang, H., & Li, W. (2025). Finasteride Use Does Not Lead to Depression or Suicide: Insights From a Large-Scale Cohort Study and Mendelian Randomization Analysis. Journal of Cosmetic Dermatology, 24(12), e70579. https://doi.org/10.1111/jocd.70579
Junge, A., Radonjic-Hoesli, S., Bossart, S., Simon, D., De Viragh, P., Hunger, R. E., Heidemeyer, K., & Seyed Jafari, S. M. (2025). Contact Dermatitis Caused by Topical Minoxidil: Allergy or Just Irritation. Acta Dermato-venereologica, 105, adv42401. https://doi.org/10.2340/actadv.v105.42401





